期刊文献+

骨折伴全身炎症反应综合征患者抵抗素和降钙素原的变化 被引量:2

原文传递
导出
摘要 [目的]探讨骨折伴全身炎症反应综合征(systemic inflammatory response syndrome,SIRS)患者血抵抗素、血降钙素原的变化及意义。[方法]应用AIS2005分析2012年1月-2013年3月骨折患者150例,男117例,女33例,年龄17—81岁,平均(39.2±14.4)岁。ELISA方法检测血抵抗素,ELFA方法检测血降钙素原。[结果]骨折患者SIRS组血抵抗素、血降钙素原高于非SIRS组(P〈0.01);骨折患者血抵抗素与WBC、血降钙素原呈正相关(P〈0.01)。ISS≤20与ISS〉20两组血抵抗素、血降钙素原差异无统计学意义(P〉0.05)。[结论]伴SIRS骨折患者血抵抗素和血降钙素原升高,抵抗素和降钙素原联合检测有助于评估骨折患者SIRS的发生。
作者 刘富
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2014年第14期1318-1320,共3页 Orthopedic Journal of China
  • 相关文献

参考文献9

  • 1Filkova M, Senolt L, Vencovsky J. The role of resistin in inflammatory myopathies[ J ]. Curr Rheumatol Rep ,2013,6:336.
  • 2美国机动车医学促进会(AAAM).重庆市急救中心译.简明损伤定级标准2005修订本[M].重庆:重庆出版社,2005.
  • 3Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [ J ]. Crit Care Med ,2003,4 : 1250 - 1256.
  • 4Koch A, Gressner OA,Sanson E, et al. Serum resistin levels in criti- cally ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non- septic patients[ J ]. Crit Care ,2009,3:95.
  • 5Mazaki - Tovi S, Vaisbuch E, Romero R, et al. Hyperresistinemia-a novel feature in systemic infection during human preg-nancy [ J ]. Am J Reprod Immunol,2010 ,5 :358 - 369.
  • 6Jiang CY, Wang W, Tang ,IX, et al. The adipocytokine resistin stimu- lates production of proinflammatory cytokines TNF - α and IL - 6 in pancreatic acinar cells via NF - κB activation [ J ]. J Endocrinol In- vest,2013,11:986 -992.
  • 7刘少锋,杨健,刘敏.降钙素原与创伤的研究进展[J].华西医学,2012,27(5):789-793. 被引量:14
  • 8Sinning JM, Scheer AC, Adenauer V,et al. Systemic inflammatory re- sponse syndrome predicts increased mortality in patients after tran- scatheter aortic valve implantation [ J ]. Eur Heart J,2012,12 : 1459 - 1468.
  • 9黄晓,莫冰峰,尹东,孙晓彤,黄宇.老年髋部骨折后死亡的相关影响因素分析[J].中国矫形外科杂志,2013,21(8):757-761. 被引量:45

二级参考文献50

  • 1胡三保,唐子华,王绍光,吴国平,郭恒冰.老年患者髋部骨折治疗方法的选择与预后探讨[J].骨与关节损伤杂志,2004,19(10):668-670. 被引量:54
  • 2刘军,谷贵山.老年髋部骨折后死亡原因的研究进展[J].中国矫形外科杂志,2007,15(18):1400-1402. 被引量:38
  • 3Moya F, Nieto A, R-Candela JL. Calcitonin biosynthesis: evidence for a precursor[J]. Eur J Bioehem, 1975, 55(2): 407-413.
  • 4Assicot M, Bohuon C, Gendrel D, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993, 341(8844): 515-518.
  • 5Nishikura T. Procalcitonin (PCT) production in a thyroidectomized patient[J]. Intensive Care Med, 1999, 25(9): 1031.
  • 6Snider RH Jr, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997, 45(9): 552-560.
  • 7Becker KL, Nyl6n ES, White JC, et al. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors[J]. Clin Endocrinol Metab, 2004, 89(4): 1512-1525.
  • 8Morgenthaler NG, Struck J, Chancerelle Y, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection[J]. Horm Metab Res, 2003, 35(5): 290-295.
  • 9Miiller B, White JC, Nyl6n ES, et al. Ubiquitous expression of the ealcitonin-i gene in multiple tissues in response to sepsis[J]. Clin Endoerinol Metab, 2001, 86(1): 396-404.
  • 10Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue[J]. Endocrinology, 2003, 144(12): 5578-5584.

共引文献59

同被引文献9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部